165 related articles for article (PubMed ID: 17787004)
1. Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter.
Giboureau N; Emond P; Fulton RR; Henderson DJ; Chalon S; Garreau L; Roselt P; Eberl S; Mavel S; Bodard S; Fulham MJ; Guilloteau D; Kassiou M
Synapse; 2007 Dec; 61(12):962-70. PubMed ID: 17787004
[TBL] [Abstract][Full Text] [Related]
2. (E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.
Emond P; Mavel S; Zea-Ponce Y; Kassiou M; Garreau L; Bodard S; Drossard ML; Chalon S; Guilloteau D
Nucl Med Biol; 2007 Nov; 34(8):967-71. PubMed ID: 17998100
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.
Tu Z; Efange SM; Xu J; Li S; Jones LA; Parsons SM; Mach RH
J Med Chem; 2009 Mar; 52(5):1358-69. PubMed ID: 19203271
[TBL] [Abstract][Full Text] [Related]
4. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.
Kilbourn MR; Hockley B; Lee L; Sherman P; Quesada C; Frey KA; Koeppe RA
Nucl Med Biol; 2009 Jul; 36(5):489-93. PubMed ID: 19520289
[TBL] [Abstract][Full Text] [Related]
6. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of vesamicol analog (-)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter.
Kawamura K; Shiba K; Tsukada H; Nishiyama S; Mori H; Ishiwata K
Ann Nucl Med; 2006 Jul; 20(6):417-24. PubMed ID: 16922470
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and evaluation of a fluorine-18 labeled radioligand targeting vesicular acetylcholine transporter.
Yue X; Luo Z; Liu H; Kaneshige K; Parsons SM; Perlmutter JS; Tu Z
Bioorg Med Chem Lett; 2018 Nov; 28(21):3425-3430. PubMed ID: 30274694
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV).
Parent M; Bedard MA; Aliaga A; Soucy JP; Landry St-Pierre E; Cyr M; Kostikov A; Schirrmacher E; Massarweh G; Rosa-Neto P
Neuroimage; 2012 Aug; 62(1):555-61. PubMed ID: 22555071
[TBL] [Abstract][Full Text] [Related]
11. The potential of o-bromo-trans-decalinvesamicol as a new PET ligand for vesicular acetylcholine transporter imaging.
Azim MA; Kozaka T; Uno I; Miwa D; Kitamura Y; Ogawa K; Makino A; Kiyono Y; Shiba K
Synapse; 2014 Oct; 68(10):445-53. PubMed ID: 24953217
[TBL] [Abstract][Full Text] [Related]
12. (-)-o-[
Miwa D; Kitamura Y; Kozaka T; Shigeno T; Ogawa K; Taki J; Kinuya S; Shiba K
Synapse; 2020 Nov; 74(11):e22176. PubMed ID: 32500935
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.
Petrou M; Frey KA; Kilbourn MR; Scott PJ; Raffel DM; Bohnen NI; Müller ML; Albin RL; Koeppe RA
J Nucl Med; 2014 Mar; 55(3):396-404. PubMed ID: 24481024
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F]fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazines.
Sorger D; Scheunemann M; Vercouillie J; Grossmann U; Fischer S; Hiller A; Wenzel B; Roghani A; Schliebs R; Steinbach J; Brust P; Sabri O
Nucl Med Biol; 2009 Jan; 36(1):17-27. PubMed ID: 19181265
[TBL] [Abstract][Full Text] [Related]
15. Modeling of [
Schildt A; de Vries EFJ; Willemsen ATM; Moraga-Amaro R; Lima-Giacobbo B; Sijbesma JWA; Sossi V; Dierckx RAJO; Doorduin J
Mol Imaging Biol; 2020 Aug; 22(4):931-939. PubMed ID: 31907846
[TBL] [Abstract][Full Text] [Related]
16. Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter.
Yue X; Bognar C; Zhang X; Gaehle GG; Moerlein SM; Perlmutter JS; Tu Z
Appl Radiat Isot; 2016 Jan; 107():40-46. PubMed ID: 26408913
[TBL] [Abstract][Full Text] [Related]
17. Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain.
Luo Z; Liu H; Jin H; Gu J; Yu Y; Kaneshige K; Perlmutter JS; Parsons SM; Tu Z
ChemMedChem; 2018 Sep; 13(18):1978-1987. PubMed ID: 30071131
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).
Efange SM; von Hohenberg K ; Khare AB; Tu Z; Mach RH; Parsons SM
Nucl Med Biol; 2000 Nov; 27(8):749-55. PubMed ID: 11150707
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter.
Padakanti PK; Zhang X; Jin H; Cui J; Wang R; Li J; Flores HP; Parsons SM; Perlmutter JS; Tu Z
Mol Imaging Biol; 2014 Dec; 16(6):773-80. PubMed ID: 24865402
[TBL] [Abstract][Full Text] [Related]
20. Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging.
Barret O; Mazère J; Seibyl J; Allard M
J Cereb Blood Flow Metab; 2008 Sep; 28(9):1624-34. PubMed ID: 18506194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
